6th MIM Pan-African Malaria Conference

6 - 8 October 2013
Durban, South Africa

Moving towards malaria elimination: Investing in research and control

The MIM conference is the largest gathering of the malaria community and provides the ideal opportunity to showcase novel findings, innovations and ground breaking research.

Since the first MIM conference in Senegal 1997, the global face of malaria has changed considerably, with malaria elimination now a viable option in many African countries. To highlight this paradigm shift, the conference is themed:  “Moving towards malaria elimination: Investing in research and control” and has both plenary sessions and symposia dedicated to this topic.

MMV and Partners will be taking part in the following sessions:

Download the following information as a PDF flyer

Symposium 8: Delivering on the promise of better medicines for children

Monday 7 October, 13.30-15.00 - Location: Meeting Room 21

Co-chairs: George Jagoe, MMV, Switzerland & Dr Josephine Namboze, WHO AFRO, Republic of Congo

Speakers:
Florence Camus-Bablon, A2Meds, MMV Consultancy, France
Hélène Degui, OCEAC, Cameroon
Kanza Nsimba Maurice, MoH, DRC
Dr Mady Ba, National Malaria Control Program, Senegal

 


 

UNITAID-led symposium 21: Improving malaria prevention, diagnosis and treatment through market-based interventions: challenges, opportunities and approaches

Tuesday 8 October, 9.30-11.00 - Location: Meeting Room 21

Co-chairs: Ms Katherine Blumer, UNITAID, Switzerland & Brenda Waning, UNITAID

Speakers:
Alexandra Cameron, UNITAID
Tom McLean, IVCC, UK
Andrea Bosman, WHO Global Malaria Programme, Switzerland
Wellington Oyibo, University of Lagos, Nigeria

 


 

Symposium 42: MMV collaborations in antimalarial drug development from discovery to access and delivery

Wednesday 9 October, 11.30-13.00 - Location: Meeting Room 22

Co-chairs:
Stephan Duparc, MMV, Switzerland & Pierre Hugo, MMV

Speakers:
Kelly Chibale, University of Cape Town, South Africa
Issaka Sagara, University of Bamako, Mali
Azra Ghani, Imperial College London, UK
Christian Burri, Swiss TPH, Switzerland

 


 

LSHTM-led symposium 46: Implementing Seasonal Malaria Chemoprevention: putting research into practice

Wednesday 9 October, 15.00-16.30 - Location: Meeting Room 22

Co-chairs: Ogobara Doumbo, Bamako University, Mali, Paul Milligan & Daniel Chandramohan, LSHTM, UK

Speakers:
Claude Emile Rwagacondo, West Africa RBM Sub Regional Network, Senegal
Jean Louis Ndiaye, University of Cheikh Anta Diop, Senegal and Mady Ba, PNLP, Senegal
Estrella Lasry, MSF, USA and Alassane Dicko, MRTC, Mali
Ebenezer Baba, Malaria Consortium, Nigeria
Aleksandra Misiorowska, MMV, Switzerland
Oumar Gaye, University Cheikh Anta Diop, Senegal
UNITA ID-led symposium 21 Peter Olumese, Global Malaria Programme, WHO, Geneva

 


 

Symposium 61: Multiple first-line therapies and protecting the ACT class of medicines: science, modelling and current practices

Thursday 10 October, 13.30-15.00 - Location: Meeting Room 21

Co-chairs: George Jagoe, MMV, Switzerland & Hellen Gelband, CDDEP, USA

Speakers:
Keziah Malm, National Malaria Control Programme, Ghana
John Amuasi, Public Health Researcher, Ghana
Hellen Gelband, CDDEP
Ian Hastings, Liverpool School of Tropical Medicine, UK

 


 

Poster: Population pharmacokinetic modelling and simulation of pyronaridine in paediatric malaria patients

Tuesday 8 October 10.30-11.30 and 12.30-13.30 - Location: Exhibition Hall

Authors: Stephan Duparc, MMV, Switzerland, Janthima Methaneethorn, University of Iowa, USA, Isabelle Borghini-Fuhrer, MMV, Jang-Sik Shin, Shin Poong, South Korea, Donald Jung, Pharmaceutical Research Services, USA, Lawrence Fleckenstein, University of Iowa

Poster: Ex vivo resistance profile of Plasmodium falciparum isolates recently collected in Abidjan, Côte d’Ivoire

Wednesday 9 October 10.30-11.30 and 12.30-13.30 - Location: Exhibition Hall

Authors: Kigbafori Silué, CSRS, Côte d’Ivoire, Sarah Mara, CSRS, Côte d’Ivoire and Xavier Ding, MMV, Switzerland

George Jagoe

MMV's George Jagoe co-chaired the symposiums "Delivering on the promise of better medicines for children" and "Multiple first-line therapies and protecting the ACT class of medicines: science, modelling and current practices"

Stephan Duparc

MMV's Stephan Duparc co-chaired the symposium "MMV collaborations in antimalarial drug development from discovery to access and delivery" and presented the poster, "Population pharmacokinetic modelling and simulation of pyronaridine in paediatric malaria patients"

Pierre Hugo

MMV's Pierre Hugo co-chaired the symposium "MMV collaborations in antimalarial drug development from discovery to access and delivery"